Form D · Biotechnology
BRAINBOX SOLUTIONS, INC.
Richmond, VA · CIK 0001834504
Offering snapshot reported Nov 7, 2023 · SEC filing
- Reported sold
- $7.09M Offering amount: $18.5M
- Investors reported
- 32 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 26, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2023 | Initial | $7,089,159 | No comparison | 32 | SEC filing |
| Mar 9, 2022 | Amendment | $18,907,129 | $12,993,553vs Dec 2, 2020 | 56 | SEC filing |
| Dec 2, 2020 | Initial | $5,913,576 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-496697
Source: Form D, filed Nov 7, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vikram Chaudhery | Director |
| Donna Edmonds | Director, Executive |
| Scott Gazelle | Director |
| Marc Goldberg | Director, Executive |
| Robert Sledd | Director |
| Steve Wallace | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
737 N 5th St. Ste 304
Richmond, VA, 23219
Richmond, VA, 23219